Recruiting

Lactate & CBF

Sponsor:

University of Missouri-Columbia

Code:

NCT06791837

Conditions

Diabetes

Obesity

Eligibility Criteria

Sex: All

Age: 18 - 45

Healthy Volunteers: Accepted

Interventions

EXERCISE

Study Details

Brief summary:

Cerebral blood flow (CBF) is essential for maintaining brain health and function, as it ensures delivery oxygen and nutrients necessary to support neuronal activity. Reduced CBF can impair the brain's ability to meet its metabolic demands, leading to deficits in cognitive ability. Impairments in CBF are associated with cognitive decline and neurodegenerative disease such as Alzheimer's and dementia. Many factors influence CBF, but recently lactate has emerged as a key player. Blood glucose has long been considered the primary fuel for the brain, but emerging evidence indicates that lactate may be the preferred fuel for neurons, and lactate may become even more important under stressful conditions.

Individuals with obesity often have impaired lactate metabolism resulting in higher resting blood lactate concentrations and reduced ability to clear lactate after a physiological stress. At the same time, it is known that exercise is a powerful intervention for improving lactate metabolism.

Thus, this project seeks to investigate the role of lactate in brain blood flow in individuals with and without obesity as well as establish if short term exercise training (individuals with obesity only) will alter circulating lactate concentrations at rest and in response to exercise.

Conditions

Diabetes

Obesity

Study ID

NCT06791837

Start date

May 1, 2025

Status verified date

Nov, 2025

Completion date

Mar 1, 2027

Anticipated

Primary completion date

Mar 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 45

Healthy Volunteers: Accepted

Inclusion Criteria:

healthy adult men and women 18-45 years of age BMI 18-40 kg/m2 not pregnant, premenopausal with regular menstrual cycles not breastfeeding non-nicotine users

Exclusion Criteria:

medications known to affect sleep, autonomic control, blood lactate levels or metabolic, or cardiovascular function (PI discretion) self-reported history of hepatic, renal, pulmonary, cardiovascular, or neurological disease, stroke or neurovascular disease, bleeding/clotting disorders, sleep apnea or other sleep disorders, diabetes, history of alcoholism or substance abuse major cardiovascular event or surgical procedure within the past three months hypertension (>140/90 mmHg or at PIs discretion).

\-

Study Design

Enrollment

24 participants

Anticipated

Interventions and Outcome Measures

Arms

non-obese

individuals with a BMI<25 kg/m2

obese

individuals with a BMI 30-40 kg/m2

Interventions

EXERCISE

each group will undergo a max test and a submaximal exercise test

Primary outcome measure

  • brain blood flow [ Time Frame: over the 30 minutes of testing ]

Central Contacts and Locations

Central contacts

Locations

University of Missouri

Recruiting

Columbia, Missouri, United States, 65211

Contacts

Principal Investigator:

Jill Kanaley, PhD

More Information

Sponsor

University of Missouri-Columbia

Last update posted

Nov 26, 2025

Last verified

Nov, 2025

Keywords

  • lactate
  • obesity
  • exercise

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Missouri-Columbia on 2025-11-26.